{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:57:04Z","timestamp":1779303424808,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11010-015-2435-x","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T15:32:44Z","timestamp":1431617564000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat"],"prefix":"10.1007","volume":"406","author":[{"given":"Saifudeen","family":"Ismael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreeja","family":"Purushothaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. S.","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Renuka","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"2435_CR1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mce.2012.06.015","volume":"366","author":"J Nagendran","year":"2013","unstructured":"Nagendran J, Waller TJ, Dyck JRB (2013) AMPK signalling and the control of substrate use in the heart. Mol Cell Endocrinol 366:180\u2013193. doi: 10.1016\/j.mce.2012.06.015","journal-title":"Mol Cell Endocrinol"},{"key":"2435_CR2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","volume":"104","author":"J Mathew","year":"2001","unstructured":"Mathew J, Sleight P, Lonn E et al (2001) Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104:1615\u20131621","journal-title":"Circulation"},{"key":"2435_CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","volume":"97","author":"P Verdecchia","year":"1998","unstructured":"Verdecchia P, Schillaci G, Borgioni C et al (1998) Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97:48\u201354","journal-title":"Circulation"},{"key":"2435_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.jhh.1001450","volume":"16","author":"MH Olsen","year":"2002","unstructured":"Olsen MH, Wachtell K, Borch-Johnsen K et al (2002) A blood pressure independent association between glomerular albumin leakage and electrocardiographic left ventricular hypertrophy. The life study. Losartan intervention for endpoint reduction. J Hum Hypertens 16:591\u2013595. doi: 10.1038\/sj.jhh.1001450","journal-title":"J Hum Hypertens"},{"key":"2435_CR5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.HYP.0000017827.63253.16","volume":"39","author":"AS Pachori","year":"2002","unstructured":"Pachori AS, Numan MT, Ferrario CM et al (2002) Blood pressure-independent attenuation of cardiac hypertrophy by AT1R-AS gene therapy. Hypertension 39:969\u2013975. doi: 10.1161\/01.HYP.0000017827.63253.16","journal-title":"Hypertension"},{"key":"2435_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","volume":"49","author":"E Takimoto","year":"2007","unstructured":"Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241\u2013248. doi: 10.1161\/01.HYP.0000254415.31362.a7","journal-title":"Hypertension"},{"key":"2435_CR7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/jmcc.2002.1526","volume":"34","author":"DB Sawyer","year":"2002","unstructured":"Sawyer DB, Siwik DA, Xiao L et al (2002) Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34:379\u2013388. doi: 10.1006\/jmcc.2002.1526","journal-title":"J Mol Cell Cardiol"},{"key":"2435_CR8","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI9056","volume":"105","author":"PM Barger","year":"2000","unstructured":"Barger PM, Brandt JM, Leone TC et al (2000) Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 105:1723\u20131730. doi: 10.1172\/JCI9056","journal-title":"J Clin Invest"},{"key":"2435_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4330\/wjc.v5.i6.164","volume":"5","author":"T Kim","year":"2013","unstructured":"Kim T, Yang Q (2013) Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system. World J Cardiol 5:164\u2013174. doi: 10.4330\/wjc.v5.i6.164","journal-title":"World J Cardiol"},{"key":"2435_CR10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1023\/B:PHAM.0000041444.06122.8d","volume":"21","author":"DH Raalte Van","year":"2004","unstructured":"Van Raalte DH, Li M, Pritchard PH, Wasan KM (2004) Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. Pharm Res 21:1531\u20131538","journal-title":"Pharm Res"},{"key":"2435_CR11","doi-asserted-by":"crossref","first-page":"H136","DOI":"10.1152\/ajpheart.01417.2006","volume":"295","author":"M Iemitsu","year":"2008","unstructured":"Iemitsu M, Shimojo N, Maeda S et al (2008) The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations. Am J Physiol Heart Circ Physiol 295:H136\u2013H144. doi: 10.1152\/ajpheart.01417.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2435_CR12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/aps.2009.58","volume":"30","author":"W Linz","year":"2009","unstructured":"Linz W, Wohlfart P, Baader M et al (2009) The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats. Acta Pharmacol Sin 30:935\u2013946. doi: 10.1038\/aps.2009.58","journal-title":"Acta Pharmacol Sin"},{"key":"2435_CR13","first-page":"470","volume":"36","author":"H Chen","year":"2007","unstructured":"Chen H, Chen J, Wang X, Yu M (2007) PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats. Zhejiang Da Xue Xue Bao Yi Xue Ban 36:470\u2013476","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"Suppl 48","key":"2435_CR14","doi-asserted-by":"crossref","first-page":"284S","DOI":"10.1042\/CS103S284S","volume":"108","author":"T Ogata","year":"2002","unstructured":"Ogata T, Miyauchi T, Sakai S et al (2002) Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin Sci 108(Suppl 48):284S\u2013288S. doi: 10.1042\/CS103S284","journal-title":"Clin Sci"},{"key":"2435_CR15","doi-asserted-by":"crossref","first-page":"44390","DOI":"10.1074\/jbc.M103826200","volume":"276","author":"ME Young","year":"2001","unstructured":"Young ME, Laws FA, Goodwin GW, Taegtmeyer H (2001) Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem 276:44390\u201344395. doi: 10.1074\/jbc.M103826200","journal-title":"J Biol Chem"},{"key":"2435_CR16","doi-asserted-by":"crossref","first-page":"H1899","DOI":"10.1152\/ajpheart.01014.2005","volume":"290","author":"EE Morgan","year":"2006","unstructured":"Morgan EE, Rennison JH, Young ME et al (2006) Effects of chronic activation of peroxisome proliferator-activated receptor-\u03b1 or high-fat feeding in a rat infarct model of heart failure. Am J Physiol Heart Circ Physiol 290:H1899\u2013H1904. doi: 10.1152\/ajpheart.01014.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2435_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10741-010-9208-0","volume":"17","author":"S Sarma","year":"2012","unstructured":"Sarma S, Ardehali H, Gheorghiade M (2012) Enhancing the metabolic substrate: PPAR-alpha agonists in heart failure. Heart Fail Rev 17:35\u201343. doi: 10.1007\/s10741-010-9208-0","journal-title":"Heart Fail Rev"},{"key":"2435_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yjmcc.2011.04.001","volume":"51","author":"B Lauzier","year":"2011","unstructured":"Lauzier B, Merlen C, Vaillant F et al (2011) Post-translational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J Mol Cell Cardiol 51:99\u2013108. doi: 10.1016\/j.yjmcc.2011.04.001","journal-title":"J Mol Cell Cardiol"},{"key":"2435_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jmcc.1996.0257","volume":"29","author":"T Tanaka","year":"1997","unstructured":"Tanaka T, Sohmiya K, Kawamura K (1997) Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29:121\u2013127. doi: 10.1006\/jmcc.1996.0257","journal-title":"J Mol Cell Cardiol"},{"key":"2435_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10557-008-6084-0","volume":"22","author":"F Labarthe","year":"2008","unstructured":"Labarthe F, G\u00e9linas R, Des Rosiers C (2008) Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc Drugs Ther 22:97\u2013106. doi: 10.1007\/s10557-008-6084-0","journal-title":"Cardiovasc Drugs Ther"},{"key":"2435_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-011-0711-y","volume":"351","author":"S Purushothaman","year":"2011","unstructured":"Purushothaman S, Renuka Nair R, Harikrishnan VS, Fernandez AC (2011) Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat. Mol Cell Biochem 351:59\u201364. doi: 10.1007\/s11010-011-0711-y","journal-title":"Mol Cell Biochem"},{"key":"2435_CR22","doi-asserted-by":"crossref","first-page":"H1229","DOI":"10.1152\/ajpheart.00779.2003","volume":"286","author":"EA Aiello","year":"2004","unstructured":"Aiello EA, Villa-Abrille MC, Escudero EM et al (2004) Myocardial hypertrophy of normotensive Wistar-Kyoto rats. Am J Physiol Heart Circ Physiol 286:H1229\u20131235. doi: 10.1152\/ajpheart.00779.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2435_CR23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","volume":"52","author":"JA Buege","year":"1978","unstructured":"Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Meth Enzymol 52:302\u2013310","journal-title":"Meth Enzymol"},{"key":"2435_CR24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2[\u2212\u0394\u0394C(T)] method. Methods 25:402\u2013408. doi: 10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"2435_CR25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/hr.2009.107","volume":"32","author":"SJ Shin","year":"2009","unstructured":"Shin SJ, Lim JH, Chung S et al (2009) Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats. Hypertens Res 32:835\u2013845. doi: 10.1038\/hr.2009.107","journal-title":"Hypertens Res"},{"key":"2435_CR26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yjmcc.2003.11.004","volume":"36","author":"QN Diep","year":"2004","unstructured":"Diep QN, Benkirane K, Amiri F et al (2004) PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. J Mol Cell Cardiol 36:295\u2013304. doi: 10.1016\/j.yjmcc.2003.11.004","journal-title":"J Mol Cell Cardiol"},{"key":"2435_CR27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2337\/dc08-0118","volume":"31","author":"GT Chew","year":"2008","unstructured":"Chew GT, Watts GF, Davis TME et al (2008) Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction. Diabetes Care 31:1502\u20131509. doi: 10.2337\/dc08-0118","journal-title":"Diabetes Care"},{"key":"2435_CR28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.HYP.0000153317.06072.2e","volume":"45","author":"T Vera","year":"2005","unstructured":"Vera T, Taylor M, Bohman Q et al (2005) Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice. Hypertension 45:730\u2013735. doi: 10.1161\/01.HYP.0000153317.06072.2e","journal-title":"Hypertension"},{"key":"2435_CR29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1139\/y99-149","volume":"78","author":"RK Shatara","year":"2000","unstructured":"Shatara RK, Quest DW, Wilson TW (2000) Fenofibrate lowers blood pressure in two genetic models of hypertension. Can J Physiol Pharmacol 78:367\u2013371. doi: 10.1139\/y99-149","journal-title":"Can J Physiol Pharmacol"},{"key":"2435_CR30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/HJH.0b013e32835e8227","volume":"31","author":"K Gilbert","year":"2013","unstructured":"Gilbert K, Nian H, Yu C et al (2013) Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension. J Hypertens 31:820\u2013829. doi: 10.1097\/HJH.0b013e32835e8227","journal-title":"J Hypertens"},{"key":"2435_CR31","doi-asserted-by":"crossref","first-page":"23661","DOI":"10.1074\/jbc.M100942200","volume":"276","author":"T Hajri","year":"2001","unstructured":"Hajri T, Ibrahimi A, Coburn CT et al (2001) Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 276:23661\u201323666. doi: 10.1074\/jbc.M100942200","journal-title":"J Biol Chem"},{"key":"2435_CR32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cbf.1449","volume":"26","author":"IK Adiga","year":"2008","unstructured":"Adiga IK, Nair RR (2008) Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy. Cell Biochem Funct 26:346\u2013351. doi: 10.1002\/cbf.1449","journal-title":"Cell Biochem Funct"},{"key":"2435_CR33","first-page":"127","volume":"111","author":"R Preeta","year":"2000","unstructured":"Preeta R, Nair RR (2000) Superoxide anions mediate proliferative response in cardiac fibroblasts. Indian J Med Res 111:127\u2013132","journal-title":"Indian J Med Res"},{"key":"2435_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-008-9803-8","volume":"317","author":"W Zhao","year":"2008","unstructured":"Zhao W, Zhao T, Chen Y et al (2008) Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem 317:43\u201350. doi: 10.1007\/s11010-008-9803-8","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"2435_CR35","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1194\/jlr.M040451","volume":"54","author":"MK Montgomery","year":"2013","unstructured":"Montgomery MK, Osborne B, Brown SHJ et al (2013) Contrasting metabolic effects of medium versus long-chain fatty acids in skeletal muscle. J Lipid Res 54(12):3322\u20133333. doi: 10.1194\/jlr.M040451","journal-title":"J Lipid Res"},{"key":"2435_CR36","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1111\/j.1582-4934.2008.00484.x","volume":"13","author":"C-B Li","year":"2009","unstructured":"Li C-B, Li X-X, Chen Y-G et al (2009) Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension. J Cell Mol Med 13:4444\u20134452. doi: 10.1111\/j.1582-4934.2008.00484.x","journal-title":"J Cell Mol Med"},{"key":"2435_CR37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mce.2013.03.006","volume":"370","author":"J Zou","year":"2013","unstructured":"Zou J, Le K, Xu S et al (2013) Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-alpha partly via preventing p65-NF\u03baB binding to NFATc4. Mol Cell Endocrinol 370:103\u2013112. doi: 10.1016\/j.mce.2013.03.006","journal-title":"Mol Cell Endocrinol"},{"key":"2435_CR38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/FJC.0b013e3180544540","volume":"49","author":"F Brigadeau","year":"2007","unstructured":"Brigadeau F, Gel\u00e9 P, Wibaux M et al (2007) The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy. J Cardiovasc Pharmacol 49:408\u2013415. doi: 10.1097\/FJC.0b013e3180544540","journal-title":"J Cardiovasc Pharmacol"},{"key":"2435_CR39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yjmcc.2006.05.013","volume":"41","author":"S Ichihara","year":"2006","unstructured":"Ichihara S, Obata K, Yamada Y et al (2006) Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. J Mol Cell Cardiol 41:318\u2013329. doi: 10.1016\/j.yjmcc.2006.05.013","journal-title":"J Mol Cell Cardiol"},{"key":"2435_CR40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.107.092403","volume":"50","author":"NK Lebrasseur","year":"2007","unstructured":"Lebrasseur NK, Duhaney T-AS, De Silva DS et al (2007) Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension. Hypertension 50:489\u2013496. doi: 10.1161\/HYPERTENSIONAHA.107.092403","journal-title":"Hypertension"},{"key":"2435_CR41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.lfs.2012.10.022","volume":"92","author":"W Dhahri","year":"2013","unstructured":"Dhahri W, Couet J, Roussel \u00c9 et al (2013) Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload. Life Sci 92:26\u201334. doi: 10.1016\/j.lfs.2012.10.022","journal-title":"Life Sci"},{"key":"2435_CR42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/FJC.0b013e31822368d7","volume":"58","author":"S Purushothaman","year":"2011","unstructured":"Purushothaman S, Sathik MM, Nair RR (2011) Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart. J Cardiovascul Pharmacol 58:254\u2013262. doi: 10.1097\/FJC.0b013e31822368d7","journal-title":"J Cardiovascul Pharmacol"},{"key":"2435_CR43","doi-asserted-by":"crossref","first-page":"H741","DOI":"10.1152\/ajpheart.1991.261.3.H741","volume":"261","author":"D Burkhoff","year":"1991","unstructured":"Burkhoff D, Weiss RG, Schulman SP et al (1991) Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Physiol Heart Circ Physiol 261:H741\u2013H750","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2435_CR44","doi-asserted-by":"crossref","first-page":"H1425","DOI":"10.1152\/ajpheart.00722.2004","volume":"288","author":"F Labarthe","year":"2005","unstructured":"Labarthe F, Khairallah M, Bouchard B et al (2005) Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. Am J Physiol Heart Circ Physiol 288:H1425\u2013H1436","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2435_CR45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ajcn\/70.6.1001","volume":"70","author":"FB Hu","year":"1999","unstructured":"Hu FB, Stampfer MJ, Manson JE et al (1999) Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 70:1001\u20131008","journal-title":"Am J Clin Nutr"},{"key":"2435_CR46","first-page":"H1425","volume":"288","author":"F Labarthe","year":"2004","unstructured":"Labarthe F (2004) Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid. AJP: heart and circulatory. Physiology 288:H1425\u2013H1436. doi: 10.1152\/ajpheart.00722.2004","journal-title":"Physiology"},{"key":"2435_CR47","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1073\/pnas.1132094100","volume":"100","author":"H Irie","year":"2003","unstructured":"Irie H, Krukenkamp IB, Brinkmann JFF et al (2003) Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci USA 100:6819\u20136824. doi: 10.1073\/pnas.1132094100","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2435-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-015-2435-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-015-2435-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T03:05:12Z","timestamp":1566702312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-015-2435-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2435"],"URL":"https:\/\/doi.org\/10.1007\/s11010-015-2435-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]}}}